Literature DB >> 14997935

Selective expression of a subset of neuronal genes in oligodendroglioma with chromosome 1p loss.

Akitake Mukasa1, Keisuke Ueki, Xijin Ge, Shumpei Ishikawa, Takafumi Ide, Takamitsu Fujimaki, Ryo Nishikawa, Akio Asai, Takaaki Kirino, Hiroyuki Aburatani.   

Abstract

Gliomas are classified based mainly on microscopic resemblance to their presumed glial origin such as astrocyte and oligodendrocyte. However, more objective diagnostic criteria are indispensable for the precise treatment of patients. For instance, loss of the short arm of chromosome 1 (1p) in oligodendrogliomas is recognized as an important marker for better response to chemotherapy and longer survival of the patients. To gain insight into their molecular biological background and to identify genes characterizing each subgroup, we investigated gene expression profile of the 4 glioma subsets, oligodendroglioma with and without 1p loss, diffuse astrocytoma and glioblastoma using DNA microarray. Remarkably, most of the genes showing distinctive expression in oligodendroglioma with 1p loss were also highly expressed in normal brain tissues and had neuron-related function, which included MYT1L, INA, RIMS2, SNAP97 and SNCB. Histological analysis also demonstrated that MYT1L, which were abundantly expressed in normal neuron, were certainly present in tumor cells. These results suggest that oligodendroglioma, especially with 1p loss, has more or less neuronal characteristics although oligodendroglioma is thought to originate form glial lineage cell. With further pathological studies, those neuron-related genes might be good diagnostic markers for oligodendroglioma of better prognosis as well.

Entities:  

Mesh:

Year:  2004        PMID: 14997935     DOI: 10.1111/j.1750-3639.2004.tb00495.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  16 in total

1.  Quantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletion.

Authors:  Robert C Rostomily; Donald E Born; Richard P Beyer; Jinghua Jin; Ellsworth C Alvord; Andrei M Mikheev; Russell T Matthews; Catherine Pan; Leila Khorasani; Josh A Sonnen; Thomas J Montine; Min Shi; Jing Zhang
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

2.  Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas.

Authors:  Sergei I Bannykh; C Claus Stolt; Jung Kim; Arie Perry; Michael Wegner
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

3.  Non-invasive genotype prediction of chromosome 1p/19q co-deletion by development and validation of an MRI-based radiomics signature in lower-grade gliomas.

Authors:  Yuqi Han; Zhen Xie; Yali Zang; Shuaitong Zhang; Dongsheng Gu; Mu Zhou; Olivier Gevaert; Jingwei Wei; Chao Li; Hongyan Chen; Jiang Du; Zhenyu Liu; Di Dong; Jie Tian; Dabiao Zhou
Journal:  J Neurooncol       Date:  2018-08-10       Impact factor: 4.130

4.  Myt1 and Myt1l transcription factors limit proliferation in GBM cells by repressing YAP1 expression.

Authors:  Tiffany A Melhuish; Izabela Kowalczyk; Arkadi Manukyan; Ying Zhang; Anant Shah; Roger Abounader; David Wotton
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2018-10-10       Impact factor: 4.490

5.  MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas.

Authors:  Inas S Khayal; Scott R Vandenberg; Kenneth J Smith; Colleen P Cloyd; Susan M Chang; Soonmee Cha; Sarah J Nelson; Tracy R McKnight
Journal:  Neuro Oncol       Date:  2011-08-24       Impact factor: 12.300

Review 6.  Tumor profiling: development of prognostic and predictive factors to guide brain tumor treatment.

Authors:  Stephen H Settle; Erik P Sulman
Journal:  Curr Oncol Rep       Date:  2011-02       Impact factor: 5.075

7.  Tumor prognostic factors and the challenge of developing predictive factors.

Authors:  Emma B Holliday; Erik P Sulman
Journal:  Curr Oncol Rep       Date:  2013-02       Impact factor: 5.075

8.  Switching metal ion coordination and DNA Recognition in a Tandem CCHHC-type zinc finger peptide.

Authors:  Angelique N Besold; Abdulafeez A Oluyadi; Sarah L J Michel
Journal:  Inorg Chem       Date:  2013-03-22       Impact factor: 5.165

9.  Oligodendroglial neoplasms with ganglioglioma-like maturation: a diagnostic pitfall.

Authors:  Arie Perry; Stephanie S Burton; Gregory N Fuller; Christopher A Robinson; Cheryl A Palmer; Lothar Resch; Eileen H Bigio; Meena Gujrati; Marc K Rosenblum
Journal:  Acta Neuropathol       Date:  2010-05-13       Impact factor: 17.088

10.  Interphase cytogenetics for 1p19q and t(1;19)(q10;p10) may distinguish prognostically relevant subgroups in extraventricular neurocytoma.

Authors:  Fausto J Rodriguez; Renan A Mota; Bernd W Scheithauer; Caterina Giannini; Hilary Blair; Kent C New; Kevin J Wu; Dennis W Dickson; Robert B Jenkins
Journal:  Brain Pathol       Date:  2008-08-15       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.